The National HIV Nurses Association (NHIVNA) is the leading UK professional association representing nurses in HIV care. Founded in 1998, it is a well-established and highly respected organisation committed to providing excellence in the care of those living with and affected by HIV.

The Association aims to provide an academic and educational forum for the dissemination of original nursing research in the field of HIV/AIDS. In addition, NHIVNA aims to address the communication and support needs of these nurses to assist in the promotion of best practice in the care of people with HIV. The Charity's objects are to advance education amongst members of the nursing profession about good nursing practices and to promote improved standards of nursing care of patients with HIV. In addition, NHIVNA supports research into the promotion of HIV nursing skills and aims to publish the results of such research for the benefit of the public.

The current membership of the Association is almost 350, located across the UK and Ireland. Membership benefits include subscription to the key journal HIV Nursing, the NHIVNA newsletter and free attendance at NHIVNA Study Days. For more details on the benefits of membership and how to join, please go to the Membership page.

Seeking members' views

NHIVNA values its members and seeks to empower them by three means: Research, Education and Support. The Association would be very grateful for members' views on how existing activities can be developed and enhanced. Please send your comments or suggestions to the Secretariat on




Upcoming Events

NHIVNA 21st Annual Conference

Venue: Manchester Conference Centre, Manchester, UK

The NHIVNA 21st Annual Conference (preceded by the NHIVNA Pre-conference Study Day on 26 June 2019) will be held in Manchester from 27-28 June 2019.



Public Health England warns that improved treatment and testing rates for STIs in the UK could be imperilled by cuts

Gus Cairns | 1 day ago

A review of one hundred years of diagnoses of sexually transmitted infections (STIs) in the UK......MORE


Benefits of dolutegravir treatment for all substantially outweigh the risks

Keith Alcorn | 2 days ago

Providing an antiretroviral regimen of dolutegravir, tenofovir and lamivudine to all adults li......MORE


Managing sexual and survival risks: the impact of inequity and stigma on Jamaican MSM and transwomen

Krishen Samuel | 5 days ago

Two recent qualitative studies highlight Jamaican men who have sex with men (MSM) and transgen......MORE


Women with HIV have increased risk of missed menstrual periods

Michael Carter | 6 days ago

Women living with HIV have a significantly higher risk of the menstrual disorder amenorrhea (m......MORE